Patrick J. Heron, Director, 10% Owner at Arcutis Biotherapeutics, Inc. (ARQT), bought 1,574,467 shares at $17.00 ($8.5M) on 2020-02-04, disclosed to the SEC on 2020-02-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,074,467 | $0 | 0.0% |
| 2 | $17.00 | 500,000 | $8.5M | 100.0% |
| Total | $5.40 avg | 1,574,467 | $8.5M | 100% |
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |